Table 6.
Recommendation to calculate an overall PI-RADS score, based on division from the sum-score, with tumor incidences derived from our data.
Overall PI-RADS score | Sum-score of T2W, DWI, and DCE-MRI | Number of patients (%) | Tumor incidence (% of biopsies) | Definition of the ESUR panel |
---|---|---|---|---|
1 | 3, 4 | 1 (1%) | — | Clinically significant disease highly unlikely to be present |
2 | 5, 6, 7 | 59 (41%) | 11% | Clinically significant cancer unlikely to be present |
3 | 8-9 | 36 (25%) | 19% | Clinically significant cancer is equivocal |
4 | 10–12 | 31 (22%) | 65% | Clinically significant cancer likely to be present |
5 | 13–15 | 16 (11%) | 94% | Clinically significant cancer highly likely to be present |
Changes in comparison to the system of Röthke et al. [13] are underlined (threshold between PI-RADS 2 and 3).